Quarterly report pursuant to Section 13 or 15(d)

Cash Equivalents and Marketable Securities - Additional Information (Details)

v3.22.2.2
Cash Equivalents and Marketable Securities - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash And Cash Equivalents [Line Items]          
Long-term marketable securities $ 0   $ 0   $ 68,775,000
Investments in an unrealized loss position 137,200,000   137,200,000   176,500,000
Unrealized losses 1,336,000   1,336,000   $ 314,000
Recognition of other-than-temporary impairment $ 0 $ 0 $ 0 $ 0  
Maximum          
Cash And Cash Equivalents [Line Items]          
Marketable securities maturity period     2 years   2 years
Minimum          
Cash And Cash Equivalents [Line Items]          
Marketable securities maturity period     1 year   1 year